Pacira Biosciences
PCRX
#5835
Rank
HK$8.39 B
Marketcap
HK$186.75
Share price
0.04%
Change (1 day)
24.57%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2025 (TTM): HK$0.32 Billion

According to Pacira Biosciences 's latest financial reports the company's current earnings are HK$0.71 Billion. In 2024 the company made an earning of -HK$0.5 Billion a decrease over its 2023 earnings that were of HK$0.48 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.32 B-166.13%
2024 -HK$0.5 Billion-202.28%
2023 HK$0.48 B363.85%
2022 HK$0.10 B-76.42%
2021 HK$0.43 B180.76%
2020 HK$0.15 B-286.92%
2019 -HK$83.67 Million2428.94%
2018 -HK$3.31 Million-99%
2017 -HK$0.34 Billion12.23%
2016 -HK$0.3 Billion-1885.05%
2015 HK$16.5 M-115.65%
2014 -HK$0.11 Billion-78.95%
2013 -HK$0.51 Billion21.55%
2012 -HK$0.42 Billion41.18%
2011 -HK$0.3 Billion57.4%
2010 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Recro Pharma
REPH
HK$29.3 M-91.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-HK$0.62 Billion-289.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-HK$0.49 Billion-250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-HK$0.11 Billion-132.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-HK$0.99 Billion-401.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-HK$1.66 Billion-606.90%๐Ÿ‡บ๐Ÿ‡ธ USA